OFFICIAL PUBLICATION OF

by its subsidiary APPco

HRT shortages to continue

Nicholas O’Donoghue 20/12/2024

Shortages of hormone replacement therapy (HRT) patches are set to continue in 2025, PBS warns Pharmacists are being reminded that some, but not all, of the HRT products covered by the Therapeutic Goods Administration's (TGA's) Serious Scarcity Substitution Instrument (SSSI) are eligible for Pharmaceutical Benefits Scheme (PBS) subsidies. In an update released on Friday 20 December,

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Funding secured for non-8CPA programs

So well done to the PSA for securing this funding. So important that these very valuable program finally gets looked…

Bente Hart

Eli Lilly clarifies Mounjaro availability

Lilly doesn't have needle production facilities. That is not their fault, you can't expect them to build a needle factory…

Tony Chiang

Funding secured for non-8CPA programs

Well done! Good to see pharmacy profession progressions

Wilson Tan

Funding secured for non-8CPA programs

Medschecks are part of the 8CPA. Have already had secured funding with indexation despite no evidence of value.

Big Pharma

HRT shortages to continue

Previous Funding secured for non-8CPA programs

Next CWH continues overseas expansion

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

Previous Funding secured for non-8CPA programs

Next CWH continues overseas expansion

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.